Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

12 trials with published results (14%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.5%

3 terminated out of 85 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

7%

6 trials in Phase 3/4

Results Transparency

31%

12 of 39 completed with results

Key Signals

12 with results93% success

Data Visualizations

Phase Distribution

56Total
Not Applicable (30)
Early P 1 (2)
P 1 (11)
P 2 (7)
P 3 (5)
P 4 (1)

Trial Status

Completed39
Recruiting15
Unknown11
Not Yet Recruiting7
Withdrawn5
Active Not Recruiting3

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 39 completed trials

Clinical Trials (85)

Showing 20 of 20 trials
NCT07628829Not Yet Recruiting

Neonatal Neurological Observation With Video AI

NCT05986994CompletedPrimary

Identification of a Pool of miRNA to Improve Early Management of Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy

NCT05130528Not ApplicableCompleted

Therapeutic Intervention Supporting Development From NICU to 6 Months for Infants Post Hypoxic-Ischemic Encephalopathy

NCT05971446RecruitingPrimary

Healthy Little Eyes

NCT07020091Completed

Predicting Mortality in Patients With Return of Spontaneous Circulation After Cardiac Arrest

NCT06195345Recruiting

Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)

NCT05836610Phase 4RecruitingPrimary

Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates

NCT07526233Not ApplicableCompletedPrimary

The Effect of Maternal Scent and Knitted Octopus Application on Pain in Infants Diagnosed With Neonatal Asphyxia and Receiving Therapeutic Hypothermia Treatment

NCT05778188Phase 2RecruitingPrimary

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

NCT06810284Phase 2Not Yet RecruitingPrimary

Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy

NCT04772222Phase 2CompletedPrimary

Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)

NCT06448780Phase 1RecruitingPrimary

Dose Optimization of Caffeine for HIE

NCT07411911Phase 1Not Yet Recruiting

Hydrogen In Neonatal Encephalopathy (HIE) Trial

NCT06429007Phase 1Enrolling By InvitationPrimary

A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury

NCT03657394Not ApplicableActive Not RecruitingPrimary

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries

NCT02260271Enrolling By InvitationPrimary

Florida Neonatal Neurologic Network

NCT04337697Completed

Neonatal Seizure Registry - Developmental Functional EValuation

NCT05361070Active Not Recruiting

Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy

NCT05514340Phase 2RecruitingPrimary

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

NCT07292220Not Yet RecruitingPrimary

A Study of a Blood Marker in Newborns With Brain Injury Caused by Lack of Oxygen at Birth

Scroll to load more

Research Network

Activity Timeline